Efectivity Test of Bitter Melon (Momordica charantia) and Bitter (Andrographis paniculata) Extract to T Lymphocytes Profile in Balb/C Mice

Novembya Vilansari, Muhaimin Rifa'i

Abstract


Type 2 diabetes mellitus (T2D) is a disease caused by the ineffectiveness of the body in using insulin. Intake of hypoglycemic drugs currently available only to control and normalize blood sugar levels but not to heal. The aim of this research was to confirm the effects of bitter melon (Momordica charantia) and bitter (Andrographis paniculata) extract on quantitative changes of CD4+TNF-α+ T cells. This research used 20 female mice as a probandus which were divided into 5 treatment groups: negative control, positive control, dose 1, dose 2 and dose 3. T2D was induced by STZ (streptozotocin) injection. T2D induced mice were treated with poly-herbal medicine extracts. After 14 days, spleen and liver cells were isolated for flow cytometry analysis. The analysis showed that ethanol extract of bitter melon (Momordica charantia) and bitter (Andrographis paniculata) can ameliorate type 2 diabetes mellitus mice model. This is proved by the decreasing of  CD4+TNF-α+ after administration of the poly-herbal medicine. The poly-herbal medicine also lowers blood sugar levels in mice experiencing hyperglycemia.

 

Keywords: Bitter, Bitter Melon, Diabetes Mellitus, STZ


Full Text:

PDF

References


Flaws, Bob, Lynn M. Kuchinski and Robert Casanas. 2002. The Treatment of Diabetes Mellitus with Chinese Medicine, Blue Poppy Press, USA.

Hahn, Robert A. and Inhorn, Marcia C. 2009. Anthropology and Public Health: Bridging Differences in Culture and Society, Oxford University Press, New York.

Asih, Yasmin. 1996. Keperawatan Medical-Bedah: Buku Saku dari Brunner dan Suddarth, Penerbit Buku Kedokteran EGC, Jakarta.

Pickup, John C., D. Phil and F. R. C. Path. 2004. Inflammation and Activated Innate Immunity in the Pathogenesis of Type 2 Diabetes, Diabetes Care, Vol. 27 (3), 813-823.

Joseph, Baby and Jini, D. 2013. Antidiabetic Effects of Momordica charantia (Bitter Melon) and Its Medicinal Potency, Asian Pacific Journal of Tropical Disease, Vol. 3 (2), 93-102.

Chao, Wen-Wan and Lin, Bi-Fong. 2010. Isolation and Identification of Bioactive Compounds in Andrographis paniculata (Chuanxinlian), Chinese Medicine, Vol. 5 (1), 1-15.

Arulmozhi, D. K., A. Veeranjaneyulu and S. L. Bodhankar. 2004. Neonatal Streptozotocin-Induced Rat Model of Type 2 Diabetes Mellitus: A Glance, Indian Journals of Pharmacology, Vol. 36 (4), 217-221.

Martha, S., Veldandi U. K., Devarakonda K. R., Pantam N., Thungathurthi S., and Reddy Y. N. 2009. Protective Effect of Aspirin in Relation to IGF-1 in Streptozotocin Induced Type-II Diabetic Rats, International Journals of Endocrinol Metabolism, Vol. 1, 20-25.

Rifa’i, Muhaimin, Y. Kawamoto, I. Nakashima, and H. Suzuki. 2004. Essential Roles of CD8+CD122+ Regulatory T Cells in the Maintenance of T Cell Homeostasis, The Journal of Experimental Medicine, Vol. 200 (9), 1123-1134.

Rifa’i, Muhaimin and Widodo, Nashi. Significance of Propolis Administration for Homeostasis of CD4+ CD25+ Immunoregulatory T Cells Controlling Hyperglycemia, SpringerPlus, Vol. 3 (1), 1-8.

Rifa'i, Muhaimin. 2010. Andrographolide Ameliorate Rheumatoid Arthritis by Promoting the Development of Regulatory T Cells, Journal of Tropical Life Science, Vol. 1 (1), 5-8.

Altinterim, Basar. 2012. Bitter Melon (Momordica charantia) and the Effects of Diabetes Disease, Journal of Agricultural Faculty of Uludag University, Vol. 26 (2), 65-69.


Refbacks

  • There are currently no refbacks.